Louis Philipson, MD, PhD
Louis Philipson, MD, PhD
James C. Tyree Professor of Diabetes Research and Care of Medicine
Professor of Pediatrics
Director, Kovler Diabetes Center
Specialties
- Endocrinology
Locations
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Louis Philipson, MD, PhD, is a renowned endocrinologist and a world authority on diabetes. Dr. Philipson’s clinical practice primary focus is on type 1 diabetes and rare forms of diabetes, and he has a multidisciplinary clinic to treat both adults and children. His approach to care centers around acknowledging the unique needs of each individual patient, taking into account their genetics and family history, as well as their specific diagnosis, in order to provide a customized treatment plan.
Dr. Philipson is the founding director of the Kovler Diabetes Center. Together with his colleagues, Drs. Bell, Greeley and Naylor, they have created a center for monogenic diabetes and established the first United States registry for neonatal and monogenic diabetes to follow and treat patients with complex diabetes.
For over 30 years, Dr. Philipson has been devoted to research that improves care for people with diabetes. His career first focused on cellular and translational studies related to insulin secretion, where he contributed to basic research in the control of insulin secretion via ion channels and calcium regulation in pancreatic beta cells. Currently, Dr. Philipson’s research is examining the genetic causes of diabetes and prevention of type 1 diabetes. He is also one of the principal investigators (PIs) and a member of the steering committee for the RADIANT study, a multicenter National Institute of Diabetes and Digestive and Kidney (NIDDK) Program working to identify atypical forms of diabetes (https://www.atypicaldiabetesnetwork.org/). As an accomplished author and co-author, Dr. Philipson has published over 180 peer-reviewed articles and co-edited “Atypical Diabetes,” a textbook printed by the American Diabetes Association.
Dr. Philipson has been an active member of the American Diabetes Association (ADA) for his entire career including as the 2019 President for Science & Medicine, President of the Chicago/Northern Illinois ADA Community Board, a member of the ADA National Board, and on a variety of other committees. Presently, he is part of the steering committee for the ADA-EASD Precision Diabetes Medicine initiative. Finally, Dr. Philipson is the recipient of numerous awards and accolades, most notably the Banting medal for service as part of the 79th Annual Scientific Sessions (2019) for his term as President for Medicine and Science, and in 2018, he was inducted as a Laureate of the Lincoln Academy of Illinois at the 54th Convocation, the highest civilian honor of the State of the Illinois.
Specialties
Areas of Expertise
- Hypoglycemia
Board Certifications
- Internal Medicine
Practicing Since
- 1986
Languages Spoken
- English
Medical Education
- University of Chicago Pritzker School of Medicine
Internship
- University of Chicago Medicine
Residency
- University of Chicago Medicine
Other Grad Education
- University of Chicago,PhD
Memberships & Medical Societies
- American College of Physicians
- Juvenile Diabetes Research Foundation
- American Diabetes Association
- European Association for the Study of Diabetes
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.